Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • To the Editor:
  • Footnotes
  • References
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Letter to the EditorInfectious disease Free access | 10.1172/JCI152693

Collateral effects of deletion of nlpD on rpoS and rpoS-dependent genes

Manami Tsunoi,1 Sunao Iyoda,2 and Tadayuki Iwase1

1Research Center for Medical Sciences, The Jikei University School of Medicine, Tokyo, Japan.

2Department of Bacteriology I, National Institute of Infectious Diseases, Tokyo, Japan.

Address correspondence to: Tadayuki Iwase, Research Center for Medical Sciences, The Jikei University School of Medicine, Tokyo, Japan.

Find articles by Tsunoi, M. in: PubMed | Google Scholar

1Research Center for Medical Sciences, The Jikei University School of Medicine, Tokyo, Japan.

2Department of Bacteriology I, National Institute of Infectious Diseases, Tokyo, Japan.

Address correspondence to: Tadayuki Iwase, Research Center for Medical Sciences, The Jikei University School of Medicine, Tokyo, Japan.

Find articles by Iyoda, S. in: PubMed | Google Scholar

1Research Center for Medical Sciences, The Jikei University School of Medicine, Tokyo, Japan.

2Department of Bacteriology I, National Institute of Infectious Diseases, Tokyo, Japan.

Address correspondence to: Tadayuki Iwase, Research Center for Medical Sciences, The Jikei University School of Medicine, Tokyo, Japan.

Find articles by Iwase, T. in: PubMed | Google Scholar

Published September 15, 2021 - More info

Published in Volume 131, Issue 18 on September 15, 2021
J Clin Invest. 2021;131(18):e152693. https://doi.org/10.1172/JCI152693.
© 2021 American Society for Clinical Investigation
Published September 15, 2021 - Version history
View PDF

Related articles:

Active bacterial modification of the host environment through RNA polymerase II inhibition
Inès Ambite, … , Ulrich Dobrindt, Catharina Svanborg
Inès Ambite, … , Ulrich Dobrindt, Catharina Svanborg
Research Article Inflammation Microbiology

Active bacterial modification of the host environment through RNA polymerase II inhibition

  • Text
  • PDF
Abstract

Unlike pathogens, which attack the host, commensal bacteria create a state of friendly coexistence. Here, we identified a mechanism of bacterial adaptation to the host niche, where they reside. Asymptomatic carrier strains were shown to inhibit RNA polymerase II (Pol II) in host cells by targeting Ser2 phosphorylation, a step required for productive mRNA elongation. Assisted by a rare, spontaneous loss-of-function mutant from a human carrier, the bacterial NlpD protein was identified as a Pol II inhibitor. After internalization by host cells, NlpD was shown to target constituents of the Pol II phosphorylation complex (RPB1 and PAF1C), attenuating host gene expression. Therapeutic efficacy of a recombinant NlpD protein was demonstrated in a urinary tract infection model, by reduced tissue pathology, accelerated bacterial clearance, and attenuated Pol II–dependent gene expression. The findings suggest an intriguing, evolutionarily conserved mechanism for bacterial modulation of host gene expression, with a remarkable therapeutic potential.

Authors

Inès Ambite, Nina A. Filenko, Elisabed Zaldastanishvili, Daniel S.C. Butler, Thi Hien Tran, Arunima Chaudhuri, Parisa Esmaeili, Shahram Ahmadi, Sanchari Paul, Björn Wullt, Johannes Putze, Swaine L. Chen, Ulrich Dobrindt, Catharina Svanborg

×
Collateral effects of deletion of nlpD on rpoS and rpoS-dependent genes. Reply.
Inès Ambite, … , Ulrich Dobrindt, Catharina Svanborg
Inès Ambite, … , Ulrich Dobrindt, Catharina Svanborg
Letter to the Editor Infectious disease

Collateral effects of deletion of nlpD on rpoS and rpoS-dependent genes. Reply.

  • Text
  • PDF
Abstract

Authors

Inès Ambite, Ulrich Dobrindt, Catharina Svanborg

×

To the Editor:

A seminal article, titled “Active bacterial modification of the host environment through RNA polymerase II inhibition,” was published in the JCI in February 2021 (1). The article depicts a novel bacterial phenomenon mediated by the NlpD protein, which was demonstrated using an nlpD deletion mutant, a recombinant NlpD protein (rNlpD), and an nlpD deletion mutant complemented with the nlpD-rpoS operon. The idea in this article is impressive and has a potential impact on bacteriology, especially for studies on NlpD. However, since nlpD is complicated, as marginally referred to in Supplemental Figure 5 in the article by Ambite et al., we here include detailed information about nlpD. nlpD is positioned upstream of rpoS; rpoS encodes the RNA polymerase sigma factor σ38 (RpoS) that regulates many genes, as shown in a recent study that identified differential expression of 1044 genes between the wild-type and rpoS mutant (2). Importantly, nlpD includes rpoS promoters, including the P2 promoter, which is critical for rpoS expression (2–4). The nlpD deletion mutant lacks the rpoS promoter, resulting in no expression of both rpoS and nlpD. Whether the phenotypes observed in the nlpD deletion mutant depend on the NlpD functions should be confirmed using nlpD and not the nlpD-rpoS operon, and we have reviewed the article by Ambite et al. with this view in mind. An nlpD SNP observed in SN25 was mapped to the critical rpoS promoter P2 “TATAAT” (5). SN25 showed low or no expression of RpoS (Supplemental Figure 5B in the article by Ambite et al.), appearing to be a mutant with substantial RpoS deficiency. No nlpD deletion mutant complemented solely with nlpD was tested; however, the mutant complemented with the nlpD-rpoS operon that expressed RpoS in addition to NlpD was studied. Furthermore, since no experiment using rNlpD SNP to confirm the phenotypes of SN25 was performed, whether these phenotypes depend on a loss of function of NlpD remains to be determined. These approaches raise the possibility that the phenotypes of SN25 observed can be attributed to the effects of rpoS/rpoS-dependent genes. We believe that this information will be useful for future studies on host-microbe interactions, especially those focusing on nlpD.

Footnotes

Conflict of interest: The authors have declared that no conflict of interest exists.

Reference information: J Clin Invest. 2021;131(18):e152693. https://doi.org/10.1172/JCI152693.

See the related article at Active bacterial modification of the host environment through RNA polymerase II inhibition.

See the related article at Collateral effects of deletion of nlpD on rpoS and rpoS-dependent genes. Reply..

References
  1. Ambite I, et al. Active bacterial modification of the host environment through RNA polymerase II inhibition. J Clin Invest. 2021;131(4):e140333.
    View this article via: JCI CrossRef PubMed Google Scholar
  2. Wong GT, et al. Genome-wide transcriptional response to varying RpoS levels in Escherichia coli K-12. J Bacteriol. 2017;199(7):e00755–16.
    View this article via: PubMed Google Scholar
  3. Takayanagi Y, et al. Structure of the 5′ upstream region and the regulation of the rpoS gene of Escherichia coli. Mol Gen Genet. 1994;243(5):525–531.
    View this article via: CrossRef PubMed Google Scholar
  4. Lange R, et al. Identification of transcriptional start sites and the role of ppGpp in the expression of rpoS, the structural gene for the sigma S subunit of RNA polymerase in Escherichia coli. J Bacteriol. 1995;177(16):4676–4680.
    View this article via: CrossRef PubMed Google Scholar
  5. Fenton MS, et al. Function of the bacterial TATAAT -10 element as single-stranded DNA during RNA polymerase isomerization. Proc Natl Acad Sci U S A. 2001;98(16):9020–9025.
    View this article via: CrossRef PubMed Google Scholar
Version history
  • Version 1 (September 15, 2021): Electronic publication

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • To the Editor:
  • Footnotes
  • References
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts